1.“They say it may cause cancer:” A qualitative exploration of Filipinos' contraceptive misconceptions and primary healthcare interventions.
Pamela Mae Q. ASEREMO ; Jayne Patricia C. HERCO ; Charlene A. PARALEON ; Azel Ruth E. PUMARAS ; Nikki M. MATIBAG ; Kevin Jace A. MIRANDA ; Rogie Royce Z. CARANDANG
Acta Medica Philippina 2025;59(11):8-17
BACKGROUND AND OBJECTIVE
Contraceptives are widely acknowledged for preventing unwanted pregnancies. However, there is a prevalent lack of awareness regarding contraceptives, leading to unaddressed misconceptions. This study aimed to identify common contraceptive misconceptions among men and women of reproductive age and explore how primary health workers address them.
METHODSA qualitative study was conducted in two phases within District 5, Manila City. Phase 1 comprised focused group discussions with men and women of reproductive age (n=60), while Phase 2 involved conducting in-depth interviews with primary healthcare providers (n=16). MAXQDA, a qualitative software, to organize and code the data, was utilized.
RESULTSWomen of reproductive age reported several misconceptions about contraceptives, including concerns about adverse health effects, emotional and behavioral changes, perceived ineffectiveness, and cosmetic or bodily changes. For instance, they believed that contraceptives could lead to serious health complications, such as cancer, genital injury, and even death. Primary healthcare providers addressed these misconceptions through open dialogue during service delivery, particularly during prenatal and postpartum check-ups and infant immunizations. They utilized patient education strategies, including the teach-back method, and conducted community outreach and workshops on contraceptives and family planning, especially during Women’s Month.
CONCLUSIONSeveral misconceptions were identified among women of reproductive age regarding the proper use and safety of contraceptive methods, as well as misguided beliefs. In contrast, men did not exhibit any misconceptions about contraceptives, which warrants further investigation. Primary healthcare providers have taken a proactive approach to address this issue by offering comprehensive explanations and ensuring clear understanding between healthcare providers and women. Promoting contraceptive health literacy could help bridge the knowledge gap between men and women of reproductive age.
Human ; Contraceptives ; Contraceptive Agents ; Health Literacy ; Philippines
3.“They say it may cause cancer:” A qualitative exploration of Filipinos' contraceptive misconceptions and primary healthcare interventions
Pamela Mae Q. Aseremo ; Jayne Patricia C. Herco ; Charlene A. Paraleon ; Azel Ruth E. Pumaras ; Nikki M. Matibag ; Kevin Jace A. Miranda ; Rogie Royce Z. Carandang
Acta Medica Philippina 2024;58(Early Access 2024):1-10
Background and Objective:
Contraceptives are widely acknowledged for preventing unwanted pregnancies. However, there is a prevalent lack of awareness regarding contraceptives, leading to unaddressed misconceptions. This study aimed to identify common contraceptive misconceptions among men and women of reproductive age and explore how primary health workers address them.
Methods:
A qualitative study was conducted in two phases within District 5, Manila City. Phase 1 comprised focused group discussions with men and women of reproductive age (n=60), while Phase 2 involved conducting in-depth interviews with primary healthcare providers (n=16). MAXQDA, a qualitative software, to organize and code the data, was utilized.
Results:
Women of reproductive age reported several misconceptions about contraceptives, including concerns about adverse health effects, emotional and behavioral changes, perceived ineffectiveness, and cosmetic or bodily changes. For instance, they believed that contraceptives could lead to serious health complications, such as cancer, genital injury, and even death. Primary healthcare providers addressed these misconceptions through open dialogue during service delivery, particularly during prenatal and postpartum check-ups and infant immunizations. They utilized patient education strategies, including the teach-back method, and conducted community outreach and workshops on contraceptives and family planning, especially during Women’s Month.
Conclusion
Several misconceptions were identified among women of reproductive age regarding the proper use and safety of contraceptive methods, as well as misguided beliefs. In contrast, men did not exhibit any misconceptions about contraceptives, which warrants further investigation. Primary healthcare providers have taken a proactive approach to address this issue by offering comprehensive explanations and ensuring clear understanding between healthcare providers and women. Promoting contraceptive health literacy could help bridge the knowledge gap between men and women of reproductive age.
contraceptives
;
contraceptive agents
;
health literacy
;
Philippines
4.Analysis of management efficacy in patients with heavy menstrual bleeding associated with antithrombotic therapy.
Xiao Lin JIANG ; Xin YAN ; Hui Na SU ; Yan Hua LIU ; Ru Xue HAN ; Zi Yi SONG ; Xiao Wan SUN ; De Hui SU ; Xin YANG
Chinese Journal of Obstetrics and Gynecology 2023;58(4):286-292
Objective: To evaluate different methods' efficacy of controlling acute bleeding and managing long-term menstruation in patients with heavy menstrual bleeding (HMB) associated with antithrombotic therapy. Methods: The clinical data of 22 cases with HMB associated with antithrombotic therapy admitted to Peking University People's Hospital from January 2010 to August 2022 were analyzed, aged 39 years old (26-46 years). Changes in menstrual volume, hemoglobin (Hb), and quality of life were collected after control of acute bleeding and long-term menstrual management. Menstrual volume was assessed by pictorial blood assessment chart (PBAC), and quality of life was assessed by menorrhagia multi-attribute scale (MMAS). Results: (1) Treatment of acute bleeding: of the 22 cases with HMB associated with antithrombotic therapy, 16 cases were treated in our hospital and 6 in other hospital for emergency bleeding; of the 16 cases treated in our hospital, 3 underwent emergency intrauterine Foley catheter balloon compression due to severe bleeding (Hb decreased by 20 to 40 g/L within 12 hours). Of the 22 cases with antithrombotic therapy-related HMB, 15 (including 2 cases with severe bleeding) underwent emergency aspiration or endometrial resection, and intraoperative placement of levonorgestrel-releasing intrauterine system (LNG-IUS) followed by a significant reduction in bleeding volume; 3 cases had controlled acute bleeding after rivaroxaban dose reduction and continued observation; 2 cases were given gonadotropin-releasing hormone agonists to control acute bleeding in other hospital, of which 1 case was temporarily treated with periodic blood transfusion, and the other one patient underwent total hysterectomy; and 2 cases had temporary amenorrhea with oral mifepristone after intrauterine balloon compression or oral norethindrone. (2) Long-term menstrual management: of the 22 cases with antithrombotic therapy-related HMB, 15 had LNG-IUS placement and 12 had LNG-IUS placement for 6 months, and menstrual volume was significantly reduced [PBAC scores were 365.0 (272.5-460.0) vs 25.0 (12.5-37.5), respectively; Z=4.593, P<0.001], Hb was significantly increased [91.5 g/L (71.8-108.2 g/L) vs 128.5 g/L (121.2-142.5 g/L); Z=4.695, P<0.001], and quality of life was significantly improved [MMAS scores were 415.0 (327.5-472.5) vs 580.0 (570.0-580.0), respectively; Z=-3.062, P=0.002] before placement compared with 6 months after placement. Three rivaroxaban dose reduction patients' PBAC scores decreased by 20 to 35 but remained >100, and perceived quality of life did not change significantly. Two cases with temporary amenorrhea treated with oral mifepristone felt significantly improved quality of life, and the MMAS scores increased by 220 and 180, respectively. Conclusion: Intrauterine Foley catheter balloon compression, aspiration or endometrial ablation could be used to control acute bleeding in patients with antithrombotic therapy-related HMB, and LNG-IUS for long-term management could reduce menstrual volume, increase hemoglobin, and improve the quality of life of patients.
Female
;
Humans
;
Adult
;
Menorrhagia/etiology*
;
Fibrinolytic Agents/adverse effects*
;
Levonorgestrel/adverse effects*
;
Amenorrhea/drug therapy*
;
Mifepristone/therapeutic use*
;
Quality of Life
;
Rivaroxaban/therapeutic use*
;
Hemoglobins
;
Intrauterine Devices, Medicated/adverse effects*
;
Contraceptive Agents, Female
5.Conversion of ISO 7439:2015 Copper-bearing Contraceptive Intrauterine Devices - Requirements and Tests Standard Analysis.
Chinese Journal of Medical Instrumentation 2022;46(1):88-90
This paper introduces the basic content of the compulsory national standard ISO 7439:2015 Copper-bearing contraceptive intrauterine devices--Requirements and tests standard analysis, and expounds the reasons for revising part of the standard during the conversion process according to the actual market situation of intrauterine contraceptive device containing copper in China. As a compulsory basic universal standard, it has a guiding significance for the manufacturers of IUD and can promote the improvement of product quality.
China
;
Contraceptive Agents
;
Copper
;
Female
;
Humans
;
Intrauterine Devices
6.Catharsis-Education-Action (CEA) method as adjunct to family planning education in the utilization of contraceptives among women of reproductive age: A randomized controlled trial
Trisha Anne M. Dael-Tenorio ; Daisy M. Medina
The Filipino Family Physician 2021;59(1):72-77
Introduction:
For the past decades, issues on Population Control have been raised. The Philippine government has been addressing these issues for quite some time. However, on the other end of the spectrum on population control, the end users have seldom been asked, understood and talked about.
Objective:
The study aimed to determine the effectiveness of Catharsis-Education-Action (CEA) Method with Family Planning Education in improving the uptake of artificial contraceptive use compared to Family Planning Education alone among women of reproductive age.
Methods:
This randomized controlled trial was conducted in a primary health center in Batangas City among 176 women of reproductive age with unmet need in family planning. Participants were randomized into either CEA counseling with Family Planning Education (intervention group) and Family Planning Education alone (control group). CEA was conducted individually with the study participants in the intervention group, following a Family Planning Education lecture provided by a midwife trained to disseminate information on family planning methods. The control group received Family Planning Education lecture alone. Outcomes were determined one month after using a Follow-up Questionnaire. Categorical variables were expressed in frequency and percentage. Chi square was used to compare the utilization rate of artificial contraceptive use between the two groups.
Results:
Baseline characteristics were similar except for the participants’ age (p-value 0.025). There was statistically significant difference in the uptake of artificial family planning method between the CEA group and control group (43% vs 27%; p-value 0.014
Conclusion
Catharsis-Education-Action (CEA) Method as adjunct to Family Planning Education is effective in improving the uptake of artificial contraceptive use among women of reproductive age. Utilizing CEA will strengthen existing primary healthcare services and establish a reproductive health plan that will enhance the overall health and well-being of women, their families and the community.
Family Planning Services
;
Contraceptive Agents
;
Sex Education
7.A comprehensive review and the pharmacologic management of primary dysmenorrhea
Journal of the Korean Medical Association 2020;63(3):171-177
Dysmenorrhea is the most common gynecologic condition in women during the reproductive period. Severe dysmenorrhea pain affects their social activities, sleep, and quality of life. Nevertheless, the proportion of women with dysmenorrhea do not receive adequate medical counseling or pharmacological treatments. Primary dysmenorrhea is diagnosed clinically, and the secondary causes that can cause pelvic pain should be identified. The treatment of choice for primary dysmenorrhea is non-steroidal anti-inflammatory drugs (NSAIDs). In order to maximize the therapeutic effect, it is necessary to ensure that the appropriate medication is administered in a proper way. NSAIDs can cause adverse effects, including gastrointestinal disorders. If side effects occur or are anticipated with NSAIDs, the use of hormonal contraceptives may be recommended when contraception is considered. In addition to these pharmacological treatments, heat, dietary, and behavioral therapies have been tried and reported to have some effects. However, further research is required for robust conclusions.
Anti-Inflammatory Agents, Non-Steroidal
;
Contraception
;
Contraceptive Agents
;
Counseling
;
Dysmenorrhea
;
Female
;
Hot Temperature
;
Humans
;
Menstruation
;
Pelvic Pain
;
Quality of Life
;
Reproduction
8.Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
Chan Hong PARK ; Sungwook CHUN
Obstetrics & Gynecology Science 2020;63(1):80-86
combined oral contraceptives (COCs) on polycystic ovarian morphology (PCOM) and serum anti-Müllerian hormone (AMH) levels in Korean women with polycystic ovary syndrome (PCOS).METHODS: This university hospital study enrolled 36 Korean women who were newly diagnosed with PCOS based on the Rotterdam criteria and were treated with COCs for at least 1 year. We retrospectively evaluated the ovarian volume and number of antral follicles using ultrasonography and assessed serum AMH levels at baseline and after 1 year of COC treatment.RESULTS: Significant decreases in ovarian volume and antral follicle count were observed after 1 year of COC treatment. Compared to baseline, serum AMH levels were significantly decreased after 1 year.CONCLUSION: COC treatment significantly affects ultrasound-assessed PCOM and serum AMH levels of patients with PCOS.]]>
Contraceptives, Oral, Combined
;
Female
;
Humans
;
Polycystic Ovary Syndrome
;
Retrospective Studies
;
Ultrasonography
9.A cross-sectional study on the knowledge, attitudes and practices on the contraceptive and non-contraceptive use of hormonal contraceptives among Filipino women in a tertiary hospital
Cialuj Teza A. Agbayani ; Melissa DL. Amosco
Philippine Journal of Reproductive Endocrinology and Infertility 2020;17(1):20-30
Background: In the Philippines, the extent to which hormonal contraceptives (HC) are used for reasons other than birth control is unknown. This study aims to examine how Filipino women use HC for contraceptive and non-contraceptive indications.
Methods: This is Project 1 of a descriptive cross-sectional study involving a hospital-based (Project 1) and community-based (Project 2) survey. The questionnaire is adapted from the Georgia Reproductive Health Survey (RHS) 2005 and The Fog Zone 2009 from Guttmacher Institute. A face-to-face questionnaire collected demographic information and issues related to knowledge, attitude and experience in HC use among 15-45-year old Filipino women (n=244) seen at the Gynecologic Outpatient Department of the Philippine General Hospital.
Results: Filipino women showed positive attitudes towards efficacy and safety of HC, which positively correlated with patterns of use. Majority possessed little knowledge regarding OCPs (82%), injectables (56%), and IUDs (39%). The major reasons for HC use were contraception (46%) and menstrual regulation (26%). Pills (77%) were most commonly utilized. A doctor’s recommendation (67%) primarily influenced choice of HC. Four out of 10 reported some difficulty in HC use.
Conclusion: Although with limited knowledge, Filipino women have positive attitude towards, and have utilized HC both for gynecologic and contraceptive purposes.
Contraceptive Agents
;
Knowledge
10.Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience
Yang WANG ; Victoria NISENBLAT ; Liyuan TAO ; XinYu ZHANG ; Hongzhen LI ; Caihong MA
Journal of Gynecologic Oncology 2019;30(3):e49-
OBJECTIVE: To evaluate the effectiveness of oral contraceptive pill (OCP) as therapy for endometrial hyperplasia (EH) without atypia in reproductive-aged women compared with oral progestin. METHODS: A retrospective cohort study was carried out in our reproductive center. Consecutive patients diagnosed with infertility and non-atypical EH identified through electronic database who met inclusion criteria (n=309). Patients were assigned to two treatment groups: OCP (n=216) and oral progestin (n=93); clinical and reproductive outcomes were recorded. RESULTS: Reversal of EH to normal endometrium, clinical pregnancy, live birth and miscarriage rate. Women in OCP group were younger, had higher prevalence of Polycystic Ovary Syndrome and other uterine pathology and longer duration of infertility than women in progestin group. Reversal of EH was observed in 93.52% women on OCP and in 86.02% women on progestin (p=0.032; adjusted odds ratio [aOR]= 2.35; 95% confidence interval [CI]=1.06-5.21) after the initial course of treatment for 2 to 6 months. Cyclic OCP (n=184) resulted in better response to treatment compared to continuous OCP (n=32) (95.11% vs. 84.38%; p=0.039; aOR =3.60; 95% CI =1.12-11.55). Clinical pregnancy rate in OCP group was marginally higher than progestin group (87/208, 41.83% vs. 27/90, 30.00%; p=0.054). Miscarriage (25.29% vs. 29.63%; p=0.654) and live birth rate (31.25% vs. 21.11%; p=0.074) were comparable between the groups. CONCLUSION: For the first time we demonstrate that OCP is an effective therapy for non-atypical EH and is associated with higher remission rate compared with oral progestin. Reproductive outcomes are reassuring and comparable between the two groups.
Abortion, Spontaneous
;
Cohort Studies
;
Contraceptives, Oral, Combined
;
Drug Therapy
;
Endometrial Hyperplasia
;
Endometrium
;
Female
;
Humans
;
Infertility
;
Live Birth
;
Odds Ratio
;
Pathology
;
Polycystic Ovary Syndrome
;
Pregnancy
;
Pregnancy Rate
;
Prevalence
;
Progestins
;
Reproductive History
;
Retrospective Studies


Result Analysis
Print
Save
E-mail